基于NGF/TRPV1信号通路探讨敛肺止咳方治疗间质性肺病相关咳嗽的机理研究
批准号:
82074422
项目类别:
面上项目
资助金额:
56.0 万元
负责人:
苗青
依托单位:
学科分类:
中医内科学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
苗青
中文摘要
咳嗽和呼吸困难是间质性肺病的主要症状,其中80%以上的间质性肺病患者被顽固性、慢性咳嗽所困扰,而咳嗽也是该类疾病进展的独立预测因子,但目前对间质性肺病相关咳嗽的发生机制缺乏深入探讨。研究表明TRPV1通道的激活可能是间质性肺病相关咳嗽的直接原因,而NGF/TRPV1信号通路则发挥了关键调节作用。本课题组多年来从事间质性肺病和慢性咳嗽的研究,提出肺失敛降、气道挛急、正气亏虚是间质性肺病相关咳嗽的病机假说,经临床证实敛肺止咳方具有较好的止咳作用,推测其机理可能与抑制NGF/TRPV1信号通路激活有关。为了验证这一假说,本课题组拟复制间质性肺病相关咳嗽的豚鼠模型,从咳嗽反应、组织病理学及分子生物学方面,研究间质性肺病相关咳嗽的发病机制,从NGF/TRPV1信号通路的基因蛋白分子表达水平,分析敛肺止咳方对NGF/TRPV1信号通路的影响,阐明间质性肺病相关咳嗽及中药干预的机理及靶点。
英文摘要
Cough and dyspnea are the main symptoms of interstitial lung disease.More than 80% of patients with interstitial lung disease are plagued by intractable and chronic cough.And coughing is an independent predictor of the progression of the disease,however,there is a lack of deeply research on the mechanism of its occurrence.Studies have shown that activation of TRPV1 channels may be a direct cause of cough associated with interstitial lung disease,and the NGF/TRPV1 signaling pathway plays a key role in regulating.Our group has been engaged in the study of interstitial lung disease and chronic cough for many years.We propose that Fei Shi Lian Jiang, Qi Dao Luan Ji,Deficiency of Vital Qi is the pathogenesis of the interstitial lung disease associated cough.It has been proved clinically that the decotion of astringe the lungs and relieve cough treatment has a good curative effect on cough.It is speculated that the mechanism may be related to inhibiting the activation of NGF/TRPV1 signaling pathway.In order to confirm this hypothesis,this study intends to replicate the guinea pig model of interstitial lung disease associated cough,to explore the pathogenesis of interstitial lung disease associated cough from the aspects of cough reaction,tissue pathology and molecular biology.From the expression level of gene protein molecules in NGF/TRPV1 signaling pathway,analyzing the influence of the decotion of astringe the lungs and relieve cough on NGF/TRPV1 signaling pathway,elucidating the mechanism of cough associated with interstitial lung disease and the mechanism and target of Chinese herbal intervention.
咳嗽是间质性肺病的主要症状之一,严重影响患者的生活质量。研究表明瞬时受体电位类香草素1(TRPV1)通道的激活可能是间质性肺病相关咳嗽的直接原因,而神经生长因子(NGF)/TRPV1信号通路则发挥了关键调节作用。本课题组提出肺失敛降、气道挛急、正气亏虚是间质性肺病相关咳嗽的病机假说,并总结出有效处方敛肺止咳方。.本研究通过建立豚鼠肺纤维化相关咳嗽模型,研究NGF/TRPV1信号通路在肺纤维化相关咳嗽发生机制中的作用;观察敛肺止咳方及其有效成分1-O-乙酰基大花旋覆花内酯(ABL)对实验动物咳嗽次数,气管及肺组织病理形态学,肺组织羟脯氨酸含量,以及对支气管肺泡灌洗液(BALF)及肺组织中NGF、TRPV1、P物质(SP)、降钙素基因相关肽(CGRP)表达等的影响,以揭示其治疗肺纤维化相关咳嗽的机理。并用TGF-β1处理BEAS-2B细胞诱导上皮细胞-间质细胞转化(EMT),通过检测细胞迁移率,NGF/TRPV1通路关键因子及EMT标志物的蛋白表达量以探究ABL改善肺纤维化的机制。.研究结果显示:(1)动物实验:敛肺止咳方可减少肺纤维化豚鼠咳嗽次数,其机制可能与减轻肺纤维化及气管上皮损伤,降低气管、肺组织 SP 蛋白表达水平有关;ABL可通过抑制NGF/TRPV1通路,降低SP、CGRP的表达,从而降低肺纤维化豚鼠的咳嗽高敏感性。(2)细胞实验:ABL通过下调NGF/TRPV1信号通路的表达,抑制BEAS-2B细胞的EMT,改善肺纤维化水平。.本研究从NGF/TRPV1信号通路揭示了肺纤维化相关咳嗽的病理机制,并证实敛肺止咳方可通过减轻肺纤维化及气管上皮损伤,改善肺纤维化豚鼠的咳嗽高敏感性;以及ABL可通过抑制NGF/TRPV1通路抑制肺纤维化进展,并通过调节神经源性炎症因子的表达降低肺纤维化豚鼠的咳嗽高敏感性。本研究为肺纤维化相关咳嗽的临床治疗提供了新的治疗思路。
止嗽散调控TRPV1和TRPA1信号通路治疗咳嗽变异性哮喘机制研究
-
批准号:81673962
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2016
-
负责人:苗青
-
依托单位:
国内基金
海外基金